PT-141

Research Studies

(for educational purposes only)

Melanocortin Receptors, Melanotropic Peptides and Penile Erection

Title: Melanocortin Receptors, Melanotropic Peptides and Penile Erection

Authors: Stephen H King, Alexander V Mayorov, Preeti Balse-Srinivasan, Victor J Hruby, Todd W Vanderah, Hunter Wessells

Published: Current Topics in Medicinal Chemistry, 2007;7(11):1098–1106

PT-141 (Bremelanotide) is a synthetic heptapeptide that represents a deaminated derivative and likely metabolite of melanotan-II (MT-II). This compound demonstrates strong binding affinity to melanocortin receptors 1, 3, and 4, with a higher affinity for MC4R over MC3R. Application of PT-141 to HEK-293 cells expressing MC4R increases cyclic adenosine monophosphate (cAMP) production, indicating that this compound, like MT-II, acts as an agonist at melanocortin receptors. This in vitro cell culture study demonstrated receptor activation through the cAMP signaling pathway, which is a key second messenger system in G-protein coupled receptor signaling. The study utilized human embryonic kidney cells (HEK-293) transfected to express the melanocortin-4 receptor, providing direct evidence of PT-141’s agonist activity at this receptor subtype through measurement of intracellular cAMP accumulation.

In plain English

This research showed that PT-141 works by binding to and activating specific protein receptors on cell surfaces called melanocortin receptors. When PT-141 attaches to these receptors on cells grown in laboratory dishes, it triggers a chain reaction inside the cells that produces more of a chemical messenger called cAMP. This proves that PT-141 functions as an activator (agonist) of these receptors, particularly the MC4R type, which is important for understanding how the drug might work in the body to affect sexual function and other processes controlled by these receptors.